---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-039365"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:29:41.159461+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Carole Ho resigns from Beam Therapeutics board effective Feb 27, 2026

## Summary
- Carole Ho notified resignation on Jan 31, 2026, effective Feb 27, 2026.
- Resignation not due to any disagreement with Beam on operations, policies, or practices.
- No successor or replacement director announced in the filing.

## SEC filing metadata
- accession: 0001193125-26-039365
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000119312526039365/0001193125-26-039365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000119312526039365/beam-20260131.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-039365
- JSON: https://secwatch.observer/filing/0001193125-26-039365.json
- Plain text: https://secwatch.observer/filing/0001193125-26-039365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.